P1225: SECONDARY PRIMARY MALIGNANCIES (SPM) AFTER HIGH-DOSE CHEMOTHERAPY (HDT) WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOMA: A DANISH NATIONWIDE COHORT STUDY

• T. Trab,
• J. Baech,
• L. Hjort Jakobsen,
• S. Husby,
• M. Tang Severinsen,
• S. Eloranta,
• J. S. Gørløv,
• J. M. Jørgensen,
• S. Gudbrandsdottir,
• T. Stauffer Larsen,
• P. Brown,
• K. E. Smedby,
• T. Christoffer El-Galaly

Affiliations

T. Trab

1 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital

J. Baech

1 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital

L. Hjort Jakobsen

1 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital

S. Husby

3 Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

M. Tang Severinsen

1 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital

S. Eloranta

4 Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden

J. S. Gørløv

3 Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

J. M. Jørgensen

5 Department of Hematology, Aarhus University Hospital, Aarhus

S. Gudbrandsdottir

6 Department of Hematology, Zealand University Hospital, Roskilde

T. Stauffer Larsen

7 Department of Hematology, Odense University Hospital, Odense, Denmark

P. Brown

3 Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

K. E. Smedby

4 Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden

T. Christoffer El-Galaly

1 Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital